secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2022-01-07T23:59:59+00:00
Accession:  0000883984-22-000005
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 2.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical completes acquisition of Smiths Medical for $1.85B cash + stock
---------------------------------------------------------------------------

- Paid $1.85B cash and issued 2.5M shares of ICUI common stock; up to $100M additional contingent cash.
- Entered into $2.2B Credit Facilities: $850M Term Loan A, $850M Term Loan B, $500M revolver.
- Pro forma combined revenue approximately $2.5 billion; Smiths adds infusion, vascular, vital care products.
- Seller (Smiths Group) gets board seat if owns >5% of ICUI; share transfer restricted for 6 months.
- Company plans to provide full FY 2022 guidance on Q4 earnings call in late February.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398422000005/0000883984-22-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398422000005/icui-20220107.htm
  HTML page:      https://secwatch.observer/filing/0000883984-22-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer